| Product Code: ETC9928780 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the United Arab Emirates |
4.2.2 Growing investments in healthcare infrastructure and research |
4.2.3 Rising awareness and demand for advanced oncology treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High costs associated with oncology-cancer drugs |
4.3.3 Limited access to specialized cancer care services in certain regions of the UAE |
5 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Trends |
6 United Arab Emirates (UAE) Oncology-Cancer Drugs Market, By Types |
6.1 United Arab Emirates (UAE) Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Imports from Major Countries |
8 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Adoption rate of innovative cancer treatments in the UAE |
8.2 Number of clinical trials for oncology drugs conducted in the UAE |
8.3 Patient survival rates and quality of life improvements post-treatment |
9 United Arab Emirates (UAE) Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 United Arab Emirates (UAE) Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here